Ebers Pharmaceuticals Ltd


BSE: 507715 | NSE: NA | ISIN: INE669D01018 
Market Cap: [Rs.Cr.] 1 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations

 Discuss this stock

Profit & Loss

(Rs. in Crores)
ParticularsMar-01Mar-00Mar-99Mar-98Mar-97Mar-96
INCOME :      
Sales Turnover 0.190.080.330.7921.588.54
Excise Duty0.000.010.040.140.290.34
Net Sales0.190.070.290.6521.298.20
Other Income 0.250.070.910.262.720.69
Stock Adjustments 0.14-0.14-0.280.040.20-0.10
Total Income0.580.000.920.9524.218.79
EXPENDITURE :      
Raw Materials 0.230.000.220.3420.986.49
Power & Fuel Cost0.000.000.040.040.220.22
Employee Cost 0.080.070.201.301.440.97
Other Manufacturing Expenses 0.030.000.050.090.300.27
Selling and Administration Expenses 0.060.130.260.510.630.69
Miscellaneous Expenses 0.160.230.060.140.480.20
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure0.560.430.832.4224.058.84
Operating Profit0.02-0.430.09-1.470.16-0.05
Interest 0.010.040.120.161.260.20
Gross Profit0.01-0.47-0.03-1.63-1.10-0.25
Depreciation0.140.130.140.140.120.06
Profit Before Tax-0.13-0.60-0.17-1.77-1.22-0.31
Tax0.000.000.000.000.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.000.000.000.000.000.00
Reported Net Profit-0.13-0.60-0.17-1.77-1.22-0.31
Extraordinary Items 0.000.000.780.000.000.00
Adjusted Net Profit-0.13-0.60-0.95-1.77-1.22-0.31
Adjst. below Net Profit 0.000.000.00-0.060.000.00
P & L Balance brought forward-6.80-6.20-6.03-4.20-2.98-2.67
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down-6.93-6.80-6.20-6.03-4.20-2.98
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.000.000.00
Earnings Per Share-Unit Curr0.000.000.000.000.000.00
Earnings Per Share(Adj)-Unit Curr0.000.000.000.000.000.00
Book Value-Unit Curr-9.97-9.59-7.85-7.38-2.031.49
Book Value(Adj)-Unit Curr-9.97-9.59-7.85-7.38-2.031.49

Related News

 
No Related News

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma 5,820.98 27.15 10.86 9.97 49.5 55.6 0.28
Sharon Bio-Med. 725.13 10.78 3.84 8.13 24.2 13.8 2.64
Kappac Pharma 692.95 0.00 22.85 0.00 0.0 0.0 0.06
Caplin Point Lab 496.74 24.48 12.37 2.62 40.6 53.9 0.16
Bliss GVS Pharma 489.73 9.08 1.56 2.75 24.2 40.6 0.17
Mahavir Advanced 397.60 0.00 45.22 0.00 0.0 0.0 0.00
Syncom Formul. 391.91 41.83 4.08 14.09 6.6 9.8 0.05
Ahlcon Parent(I) 345.60 17.72 4.70 10.50 26.9 31.2 0.41
Venus Remedies 311.40 5.11 0.67 4.21 16.1 14.4 0.69
Amrutanjan Healt 257.98 17.76 2.66 7.12 14.4 19.8 0.20
Arvind Remedies 208.81 3.54 0.79 4.80 25.2 20.1 2.73
Hester Bios 177.99 14.30 2.34 5.68 15.2 21.7 0.32
Plethico Pharma. 158.43 6.07 0.29 35.79 -5.0 1.6 1.56
Bharat Immunolog 146.60 16.48 3.47 1.11 11.6 18.5 0.12
Albert David 99.95 8.26 1.11 2.96 14.7 16.4 0.47

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

A K Rathi , Chairman 

S M Parande , Managing Director 

R Goppu , Director 

Ashok B Raval , Director 


Company Head Office / Quarters:
103 Shreepal Complex Suren Rd,
Andheri (E),
Mumbai,
Maharashtra-400093
Phone : 91-22-8367527
Fax : 91-22-8218340
E-mail :
Web : http://
Registrars:
Bigshare Services Pvt Ltd
E-2/3 Ansa Indl Est
Saki Vihar Road
Sakinaka Andheri(E)
Mumbai - 400072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Jul-2014
M T W T F S S
28 29 30 31 01 02 03
IPO
listNo IPO today
Economic Events
list Large Retailers' Sales
list Retail Trade (YoY)
Results
list ACC | GlaxoSmith C H L | Hind. Unilever | Larsen & Toubro